Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38025
CAS Number:
118288-08-7
Lafutidine
Purity:
≥ 98% (HPLC)
Synonym(s):
(Z)-2-[(Furan-2-ylmethyl)sulfinyl]-N-[4-[[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxy]but-2-en-1-yl]acetamide, 2-[(2-Furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]-acetamide
Documents
$72.31 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Lafutidine is a potent compound recognized for its role as a gastroprotective agent, primarily utilized in the treatment of gastric ulcers and gastroesophageal reflux disease (GERD). This innovative drug works by enhancing mucosal defense mechanisms and promoting healing in the gastrointestinal tract, making it a valuable option for patients suffering from acid-related disorders. Its unique structure, featuring a furan moiety and a piperidine group, contributes to its effectiveness in reducing gastric acid secretion while simultaneously providing a protective effect on the gastric mucosa.

In clinical settings, Lafutidine has demonstrated significant efficacy in alleviating symptoms associated with peptic ulcers and has been shown to improve patient outcomes when used in combination with other therapeutic agents. Researchers and healthcare professionals appreciate its favorable safety profile and the potential for reduced side effects compared to traditional treatments. With its dual action of acid suppression and mucosal protection, Lafutidine stands out as a promising candidate for advancing gastrointestinal health and enhancing patient quality of life.

Synonyms
(Z)-2-[(Furan-2-ylmethyl)sulfinyl]-N-[4-[[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxy]but-2-en-1-yl]acetamide, 2-[(2-Furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]-acetamide
CAS Number
118288-08-7
Purity
≥ 98% (HPLC)
Molecular Formula
C22H29N3O4S
Molecular Weight
431.55
MDL Number
MFCD00867520
PubChem ID
3873
Melting Point
97 - 101 °C
Appearance
White to orange to green powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
(Z)-2-[(Furan-2-ylmethyl)sulfinyl]-N-[4-[[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxy]but-2-en-1-yl]acetamide, 2-[(2-Furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]-acetamide
CAS Number
118288-08-7
Purity
≥ 98% (HPLC)
Molecular Formula
C22H29N3O4S
Molecular Weight
431.55
MDL Number
MFCD00867520
PubChem ID
3873
Melting Point
97 - 101 °C
Appearance
White to orange to green powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Lafutidine is widely utilized in research focused on:

  • Gastrointestinal Health: Lafutidine is primarily used in the treatment of gastric ulcers and gastroesophageal reflux disease (GERD). Its ability to enhance mucosal defense mechanisms makes it a preferred choice for patients looking for effective relief.
  • Pharmaceutical Development: In the pharmaceutical industry, Lafutidine serves as a model compound for developing new gastroprotective agents. Researchers study its mechanisms to create more effective treatments with fewer side effects.
  • Clinical Research: Clinical trials often investigate Lafutidine's efficacy and safety in various populations, providing valuable data that can lead to improved treatment protocols for gastrointestinal disorders.
  • Combination Therapies: Lafutidine is explored in combination with other medications to enhance therapeutic outcomes for patients with complex gastrointestinal issues, offering a tailored approach to treatment.
  • Patient Compliance: Its favorable side effect profile compared to traditional treatments encourages better patient adherence, making it a valuable option for long-term management of gastric conditions.

Citations